Growth & Secretagogue Peptides

CJC-1295 / Ipamorelin Refill 10mg

£35.00

CJC-1295 / Ipamorelin Refill 10mg — 10mg combined

Individual constituent quantities require the refill-specific specification. Supplied as the separately listed refill-cartridge presentation for in-vitro laboratory research only; not for human or veterinary use.

Request batch documentation

Description

CJC-1295 / Ipamorelin Refill 10mg is the Core Research listing for 10mg combined in the separately listed refill-cartridge presentation. Individual constituent quantities require the refill-specific specification. It is supplied for in-vitro laboratory research only, not for human or veterinary use. The exact supplied chemical form, current batch results and any finished-format specifications must be checked against the documentation applicable to this item.

What you receive and what the label means

The current catalogue identifies this product as CJC-1295 / Ipamorelin Refill 10mg. This page distinguishes the material name and labelled quantity from independently measured content. Stock and current price are supplied by the live WooCommerce purchase panel rather than duplicated as static claims in the description.

The stated nominal amount is not a prepared solution concentration, analytical purity percentage or guarantee of the number of experiments possible. Those further properties depend on the exact material form, documentation and laboratory method.

Item Detail
Catalogue product CJC-1295 / Ipamorelin Refill 10mg
Labelled amount 10mg combined
Named material / declared composition Individual constituent quantities require the refill-specific specification
Physical presentation the separately listed refill-cartridge presentation
Supply boundary Laboratory research only; no human or veterinary use

Which product format is the right catalogue item?

The related listings below differ in presentation and, where stated, composition. Do not assume their packages, compatible hardware, storage conditions or analysed content are identical merely because the molecular name overlaps. vial and pen-format comparison.

Product Declared format / relevant distinction
CJC-1295 No DAC + Ipamorelin 10mg Vial / co-lyophilised; declared 5mg + 5mg
CJC-1295 / Ipamorelin Refill 10mg (this item) Refill; constituent split requires refill specification
CJC-1295 / Ipamorelin 10mg Pen Complete preloaded pen; verify filled-format details

What does 10mg mean for this CJC-1295/Ipamorelin blend?

The refill is labelled as a 10mg combined preparation, but the precise split between the CJC-1295 No DAC and Ipamorelin components has not been verified from refill-specific evidence. Do not transfer the vial’s 5mg + 5mg declaration to this cartridge without its specification.

Research mechanisms and what studies actually found

The following sections distinguish the molecular identity, measured experimental endpoint and limitations of published work. Literature on a pure molecule, animal model or clinical formulation is not analytical evidence for this particular Core Research supply. The cited sources support the described scientific context, not a product-specific efficacy or batch claim.

Two signalling routes, not one compound

The listed combination places a growth-hormone-releasing-hormone analogue next to a growth-hormone secretagogue. The GHRH analogue is researched through the pituitary GHRH-receptor system and downstream cAMP signalling. Ipamorelin belongs to the GHRP/ghrelin-receptor class, with a distinct receptor-pharmacology history. These are complementary mechanistic hypotheses, but separate receptor classes are not proof of a synergistic response to this manufactured mixture. 1,5

Ipamorelin and the selectivity question

In early primary pituitary-cell and animal experiments, Raun and colleagues described the synthetic pentapeptide ipamorelin as a GH secretagogue with selectivity relative to other hormonal responses in their studied models. That selectivity is relative to the particular comparator, assay and observation period. It is not evidence that a finished research blend has no other biological effects or that every species responds identically. 1

Why No DAC is a critical identity distinction

The catalogue describes its CJC component as No DAC, a name commonly used for a Modified GRF(1–29)-type analogue. The long-acting CJC-1295 investigated in Teichman’s controlled pharmacology study used a Drug Affinity Complex enabling albumin interaction. The 2005 development work examined albumin conjugates. Those DAC-linked structures are not interchangeable with an unconjugated 1–29 analogue, and prolonged kinetic results measured for one should not be transferred to the other. 2,3

What human research does and does not show

Teichman and colleagues measured GH and IGF-I responses in healthy adults after exposure to DAC-linked CJC-1295. That is a pharmacodynamic observation for a specific molecule and research formulation, not a trial of this No-DAC/Ipamorelin combination. Separately, a randomised phase-2 study of ipamorelin for postoperative ileus did not establish the intended clinical benefit. Including this contrary result prevents a generic “growth hormone stimulation equals therapeutic efficacy” inference. 3,4

The blend as an experimental variable

The individual materials may be studied using different concentrations, matrices and endpoints. A co-lyophilised two-component item adds identity, relative content and interaction questions. The existence of two component literatures does not validate the combined material, prove chemical stability after preparation, or justify adding their reported results. Check both components and the actual finished format as separate analytical questions.

Finished-format checks specific to this item

Cartridge format: The refill item is listed as a separate cartridge rather than the complete pen. Ask which housing or device it is compatible with; the product name alone is not a compatibility test.

For evaluation of this finished item, identify its container, chemical species and nominal amount; confirm any prepared-solution or reconstitution state. Check pen-format verification and cartridge capacity and dispensing verification when mechanical performance matters.

What evidence exists for this exact blend?

The constituent studies describe GHRH-analogue or ipamorelin research separately; the DAC-linked CJC studies do not test No DAC. No verified controlled clinical study of this exact co-lyophilised catalogue mixture, refill formulation or manufacturing lot was established in the available records. This is a limitation of the evidence inspected, not a claim that no study can ever exist.

Batch documentation and evidence before purchase

For a pre-purchase question, use Request batch documentation or email info@core-research.net, naming CJC-1295 / Ipamorelin Refill 10mg and its refill format. You do not need a previous container lot number to enquire. Ask which dispatch lot and exact presentation any proposed report covers.

Read the certificate for sample identification, test method, analyte(s), units, measured content, chromatographic results and issuer. Identity, chromatographic purity and quantitative content answer different questions; one HPLC peak-area value alone does not prove the labelled mass. Laboratory handling and evidence requirements depend on the actual chemical form.

For context see how to read a peptide CoA, HPLC and purity testing and mass-spectrometry identity testing. These guides explain how documents are read; they do not assert that a current lot passed any unobserved test.

Additional documentation for the finished format

For this presentation, check the container and product specification in addition to material identity: fill volume or dry-fill basis, declared constituents, formulation vehicle where applicable, lot traceability, container integrity and any validated compatibility or dispensing property your method requires.

Do not automatically transfer an HPLC result, solvent condition or expiry statement from a different vial, refill, pen or manufacturing lot. Where a material attribute is essential to procurement, request it before ordering rather than assuming it from related items.

Storage, receipt and handling

Follow the storage instructions supplied for this particular product and lot. A fixed dry-material temperature or shelf life is not stated here without authenticated product-specific evidence. Solution stability, if applicable, is a separate question that can depend on solvent, pH, concentration, container and exposure history.

At receipt, inspect the material label, lot and quantity, packaging and closure against the order; record discrepancies before laboratory use. See the research-product receiving checklist and laboratory storage guidance. For late or unexpectedly warm delivery, consult warm or delayed research shipments.

Ordering and laboratory procurement questions

Can I ask for the lot documentation before ordering?

Yes. The Request batch documentation route accepts product/presentation enquiries before an order. Ask whether the available report covers the lot expected to be supplied; availability and analytical scope must not be assumed.

Does this refill include a complete pen?

No complete pen is established by the refill-only listing. It is a separately purchasable cartridge-format item. Confirm compatible hardware and any accessories with Core Research before placing an order.

Where do orders ship from?

Core Research’s published shipping policy describes dispatch from Birmingham, UK, in plain outer packaging. Available carrier options, shipping charges and tracking depend on the actual order and service. The checkout and shipping policy provide the applicable current information.

Does the labelled amount determine experimental concentration?

No. The labelled mass alone does not determine a prepared concentration, method, recovery, sample number or material content verified by assay. Those require defined volume and material-specific laboratory controls; the page provides no personal-use or administration directions.

Can an institution ask for a quotation?

Yes. The Institutional Procurement page provides a quotation and purchase-order-reference enquiry pathway. State the requested item, quantity, delivery details and any need for a particular lot or document before ordering.

What if the item arrives damaged or differs from the order?

Contact info@core-research.net with the order number, labelled product/lot identifiers and photographs. Keep the packaging and segregate the item from laboratory use until the discrepancy is addressed.

Order or enquire about CJC-1295 / Ipamorelin Refill 10mg

Use the native purchase panel for current pricing, stock and quantity selection. For an analytical or format question, contact Core Research before purchase; for shipping information see Shipping & Delivery.

The research discussed above is not a human-use instruction or a claim about medical effects of the supplied item. Read the Research Use Only policy and testing and quality methodology for the published supply and quality framework.

Selected research and identity references

[1] Raun K et al. (1998), Ipamorelin: selective GH secretagogue pharmacology. European Journal of Endocrinology. Source.

[2] Jetté L et al. (2005), GHRH analogue–albumin conjugates and their receptor activity. Endocrinology. Source.

[3] Teichman SL et al. (2006), Controlled pharmacology of DAC-linked CJC-1295 in healthy adults. Journal of Clinical Endocrinology & Metabolism. Source.

[4] Beck DE et al. (2014), Randomised ipamorelin postoperative-ileus study. International Journal of Colorectal Disease. Source.

[5] Lance VA et al. (1984), GHRH(1–29) analogue structure–activity research. Source.

Additional information

Format

Refill cartridge

Strength

10mg